Green and Black Tea Consumption and Risk of Stroke A Meta-Analysis

被引:190
作者
Arab, Lenore [1 ]
Liu, Weiqing [1 ]
Elashoff, David [1 ]
机构
[1] Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA
关键词
black tea; Camelia sinensis; green tea; ischemic stroke; theophylline; CARDIOVASCULAR-DISEASE; CEREBRAL-ISCHEMIA; UNITED-STATES; ENDOTHELIAL FUNCTION; FLAVONOID INTAKE; MALE SMOKERS; WOMEN; COST; POPULATION; HEMORRHAGE;
D O I
10.1161/STROKEAHA.108.538470
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-Experimental models of stroke provide consistent evidence of smaller stroke volumes in animals ingesting tea components or tea extracts. To assess whether a similar association of black or green tea consumption with reduced risk is evident in human populations, we sought to identify and summarize all human clinical and observational data on tea and stroke. Methods-We searched PubMed and Web of Science for all studies on stroke and tea consumption in humans with original data, including estimation or measurement of tea consumption and outcomes of fatal or nonfatal stroke. Data from 9 studies involving 4378 strokes among 194 965 individuals were pooled. The main outcome was the occurrence of fatal or nonfatal stroke. We tested for heterogeneity and calculated the summary effect estimate associated with consumption of >= 3 cups of tea (green or black) per day using random-effects and fixed-effects models for the homogeneous studies. Publication bias was also evaluated. Results-Regardless of their country of origin, individuals consuming >= 3 cups of tea per day had a 21% lower risk of stroke than those consuming <1 cup per day (absolute risk reduction, 0.79; CI, 0.73 to 0.85). The proportion of heterogeneity not explained by chance alone was 23.8%. Conclusions-Although a randomized clinical trial would be necessary to confirm the effect, this meta-analysis suggests that daily consumption of either green or black tea equaling 3 cups per day could prevent the onset of ischemic stroke. (Stroke. 2009; 40: 1786-1792.)
引用
收藏
页码:1786 / 1792
页数:7
相关论文
共 45 条
[1]   Differentiation of green, white, black, oolong, and Pu-erh teas according to their free amino acids content [J].
Alcazar, A. ;
Ballesteros, O. ;
Jurado, J. M. ;
Pablos, F. ;
Martin, M. J. ;
Vilches, J. L. ;
Navalon, A. .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2007, 55 (15) :5960-5965
[2]   The acute effect of green tea consumption on endothelial function in healthy individuals [J].
Alexopoulos, Nikolaos ;
Vlachopoulos, Charalambos ;
Aznaouridis, Konstantinos ;
Baou, Katerina ;
Vasiliadou, Carmen ;
Pietri, Panagiota ;
Xaplanteris, Panagiotis ;
Stefanadi, E. ;
Stefanadis, Christodoulos .
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2008, 15 (03) :300-305
[3]   OPERATING CHARACTERISTICS OF A BANK CORRELATION TEST FOR PUBLICATION BIAS [J].
BEGG, CB ;
MAZUMDAR, M .
BIOMETRICS, 1994, 50 (04) :1088-1101
[4]   Projected costs of ischemic stroke in the United States [J].
Brown, D. L. ;
Boden-Albala, B. ;
Langa, K. M. ;
Lisabeth, L. D. ;
Fair, M. ;
Smith, M. A. ;
Sacco, R. L. ;
Morgenstern, L. B. .
NEUROLOGY, 2006, 67 (08) :1390-1395
[5]  
Chen Zuo, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P666
[6]   Protective effect of epigallocatechin gallate on brain damage after transient middle cerebral artery occlusion in rats [J].
Choi, YB ;
Kim, YI ;
Lee, KS ;
Kim, BS ;
Kim, DJ .
BRAIN RESEARCH, 2004, 1019 (1-2) :47-54
[7]   METAANALYSIS IN CLINICAL-TRIALS [J].
DERSIMONIAN, R ;
LAIRD, N .
CONTROLLED CLINICAL TRIALS, 1986, 7 (03) :177-188
[8]   Involvement of GABAA-receptors in the neuroprotective effect of theanine on focal cerebral ischemia in mice [J].
Egashira, Nobuaki ;
Hayakawa, Kazuhide ;
Osajima, Megurni ;
Mishima, Kenichi ;
Iwasaki, Katsunori ;
Oishi, Ryozo ;
Fujiwara, Michihiro .
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2007, 105 (02) :211-214
[9]   Bias in meta-analysis detected by a simple, graphical test [J].
Egger, M ;
Smith, GD ;
Schneider, M ;
Minder, C .
BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7109) :629-634
[10]   The cost of cerebral ischaemia [J].
Flynn, R. W. V. ;
MaWalter, R. S. M. ;
Doney, A. S. F. .
NEUROPHARMACOLOGY, 2008, 55 (03) :250-256